Asset Details
Do you wish to reserve the book?
Fecal filtrate transplantation protects against necrotizing enterocolitis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Fecal filtrate transplantation protects against necrotizing enterocolitis
Do you wish to request the book?
Fecal filtrate transplantation protects against necrotizing enterocolitis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Fecal filtrate transplantation protects against necrotizing enterocolitis
2022
Overview
Necrotizing enterocolitis (NEC) is a life-threatening gastrointestinal disorder afflicting preterm infants, which is currently unpreventable. Fecal microbiota transplantation (FMT) is a promising preventive therapy, but the transfer of pathogenic microbes or toxic compounds raise concern. Removal of bacteria from donor feces by micropore filtering may reduce this risk of bacterial infection, while residual bacteriophages could maintain the NEC-preventive effects. We aimed to assess preclinical efficacy and safety of fecal filtrate transplantation (FFT). Using fecal material from healthy suckling piglets, we compared rectal FMT administration (FMT,
n
= 16) with cognate FFT by either rectal (FFTr,
n
= 14) or oro-gastric administration (FFTo,
n
= 13) and saline (CON,
n
= 16) in preterm, cesarean-delivered piglets as models for preterm infants. We assessed gut pathology and analyzed mucosal and luminal bacterial and viral composition using 16S rRNA gene amplicon and meta-virome sequencing. Finally, we used isolated ileal mucosa, coupled with RNA-Seq, to gauge the host response to the different treatments. Oro-gastric FFT completely prevented NEC, which was confirmed by microscopy, whereas FMT did not perform better than control. Oro-gastric FFT increased viral diversity and reduced Proteobacteria relative abundance in the ileal mucosa relative to control. An induction of mucosal immunity was observed in response to FMT but not FFT. As preterm infants are extremely vulnerable to infections, rational NEC-preventive strategies need incontestable safety profiles. We show in a clinically relevant animal model that FFT, as opposed to FMT, efficiently prevents NEC without any recognizable side effects.
Publisher
Nature Publishing Group UK,Oxford University Press
Subject
/ 38/91
/ 45/23
/ 64
/ Animals
/ Bacteria
/ Biomedical and Life Sciences
/ Ecology
/ Enterocolitis, Necrotizing - microbiology
/ Enterocolitis, Necrotizing - prevention & control
/ Fecal Microbiota Transplantation
/ Feces
/ Female
/ Filtrate
/ Humans
/ Infants
/ Microbial Genetics and Genomics
/ Necrosis
/ Neonates
/ Phages
/ Rectum
/ RNA, Ribosomal, 16S - genetics
/ rRNA 16S
/ Safety
/ Swine
